Ranking & Reports
Key Trends in the Pharmaceutical Pipeline for 2024 — Part II: U.S. and China Compete for Top Position in the Global Drug Development Landscape
2024-10-23
Key Trends in the Pharmaceutical Pipeline for 2024 — Part I: Transformative R&D Growth Driven by Breakthroughs in Oncology, Neurological, and Metabolic Therapies
2024-10-18
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Viking Therapeutics Ready to Make Billions as a Strong Contender in the GLP-1 Weight Loss Space
2024-08-29
LATEST
From Fabs to Labs: TSMC, Mayo Clinic, and the Next Wave of Bio-Digital Innovation in Phoenix
2025-07-17
A New Contender Rises: China’s Hengrui and Innovent Challenge Zepbound and Wegovy in Global Weight-Loss Drug Race
2025-07-16